Hydrochlorothiazide clinical uses
Pro Research Analysisby 
Searched over 200M research papers
Hydrochlorothiazide Clinical Uses: Hypertension, Kidney Stones, and Bone Health
Hydrochlorothiazide for Hypertension Treatment
Hydrochlorothiazide is widely prescribed for managing high blood pressure (hypertension). It is one of the most commonly used antihypertensive drugs, often included in combination therapies with other agents such as angiotensin receptor blockers (ARBs) . However, evidence suggests that at typical doses (12.5–25 mg daily), hydrochlorothiazide may not significantly reduce the risk of major cardiovascular events like heart attack, stroke, or death compared to other antihypertensive medications. Its blood pressure-lowering effect is also generally less than that of other drug classes, and it may be less well tolerated by patients .
When compared to chlorthalidone, another thiazide-type diuretic, hydrochlorothiazide shows similar efficacy in reducing cardiovascular outcomes, but with a lower risk of electrolyte disturbances such as hypokalemia and hyponatremia . Despite being considered interchangeable in some guidelines, chlorthalidone is more potent and has a longer duration of action, though the clinical significance of these differences remains uncertain 56.
Cardiovascular Risks and Side Effects
Chronic use of hydrochlorothiazide, especially in combination with ARBs, may have negative effects on cardiovascular health. It can increase central blood pressure, arterial stiffness, and the risk of atrial fibrillation compared to ARB therapy alone . These findings highlight the importance of careful patient selection and monitoring when using hydrochlorothiazide for hypertension, particularly in those at risk for cardiovascular complications .
Prevention of Kidney Stone Recurrence
Hydrochlorothiazide has been used to prevent the recurrence of calcium-containing kidney stones. However, recent evidence indicates that its use at doses of 12.5 mg, 25 mg, or 50 mg daily does not significantly reduce the recurrence of kidney stones compared to placebo. Additionally, patients taking hydrochlorothiazide may experience more side effects, including hypokalemia, gout, new-onset diabetes, skin allergies, and increased creatinine levels .
Effects on Bone Health in Postmenopausal Women
Hydrochlorothiazide can slow the loss of cortical bone in normal postmenopausal women. In clinical studies, it has been shown to reduce urine calcium excretion and decrease bone turnover, resulting in modest improvements in bone mineral density at several skeletal sites. However, the effect size is small, suggesting that while hydrochlorothiazide may help prevent postmenopausal bone loss, it is not suitable as a sole therapy for osteoporosis .
Conclusion
Hydrochlorothiazide is primarily used for treating hypertension and has additional roles in managing kidney stone recurrence and slowing bone loss in postmenopausal women. While it is effective in lowering blood pressure, its impact on major cardiovascular outcomes is limited, and it may carry certain risks, especially with long-term use. Its use for kidney stone prevention and bone health offers modest benefits, but these should be weighed against potential side effects. Careful consideration of patient-specific factors is essential when prescribing hydrochlorothiazide for any clinical use 1234+2 MORE.
Sources and full results
Most relevant research papers on this topic